Abstract
We assessed the relationship of renal function and the clinical outcome in 2314 patients treated by drug-eluting stent (DES). At 24 months, the cumulative major adverse cardiac events (MACE) rate and the composite of death and myocardial infarction were higher in the patients with severe chronic kidney disease (CKD). Severe CKD identifies patients at high risk of MACE following DES implantation.
Original language | English |
---|---|
Pages (from-to) | 92-94 |
Number of pages | 3 |
Journal | International Journal of Cardiology |
Volume | 142 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jun 25 2010 |
Keywords
- Chronic kidney disease
- Drug eluting stent
- Outcome
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine